Stephen Gough

Active 1994–2023

65
Papers
19,857
Citations
61
h-index
65
i10-index

Citations

Citations per year for Stephen Gough1983: 1 citations1984: 1 citations1994: 5 citations1995: 43 citations1996: 46 citations1997: 58 citations1998: 44 citations1999: 39 citations2000: 32 citations2001: 55 citations2002: 85 citations2003: 114 citations2004: 174 citations2005: 233 citations2006: 165 citations2007: 191 citations2008: 243 citations2009: 208 citations2010: 148 citations2011: 116 citations2012: 142 citations2013: 136 citations2014: 154 citations2015: 159 citations2016: 172 citations2017: 152 citations2018: 190 citations2019: 481 citations2020: 463 citations2021: 410 citations2022: 345 citations2023: 317 citations2024: 530 citations2025: 275 citations2026: 12 citations1985–1993: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,196 citing papers, 23.3% of this breakdownUnited Kingdom: 1,108 citing papers, 11.7% of this breakdownChina: 529 citing papers, 5.6% of this breakdownItaly: 489 citing papers, 5.2% of this breakdownGermany: 447 citing papers, 4.7% of this breakdownCanada: 336 citing papers, 3.6% of this breakdownAustralia: 305 citing papers, 3.2% of this breakdownNetherlands: 277 citing papers, 2.9% of this breakdownDenmark: 265 citing papers, 2.8% of this breakdownFrance: 256 citing papers, 2.7% of this breakdownJapan: 236 citing papers, 2.5% of this breakdownSpain: 219 citing papers, 2.3% of this breakdown
0%23.3%Other 29.5%

Fields

  • Medicine57.1%
  • Biochemistry, Genetics and Molecular Biology32%
  • Immunology and Microbiology7.2%
  • Neuroscience1.3%
  • Agricultural and Biological Sciences0.5%
  • Pharmacology, Toxicology and Pharmaceutics0.3%
  • Other1.6%

Topics

  • Liver Disease Diagnosis and Treatment6.7%
  • Diabetes and associated disorders6.2%
  • Diabetes Treatment and Management4.8%
  • Genetic Associations and Epidemiology4.6%
  • Pancreatic function and diabetes3.7%
  • T-cell and B-cell Immunology3.6%
  • Other70.4%

Coauthors

All papers

Open in search
  1. Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study

    Authors: , , , , , , , , , , , , , , , - The Lancet 2015 cited by 2,125

  2. The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease

    Authors: , , , , , , , , , , , , , - Nephrology Dialysis Transplantation 2023 cited by 237

  3. Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis

    Authors: , , , , , , , , , , - Journal of Hepatology 2015 cited by 447

  4. Pharmacogenomics of GLP-1 receptor agonists: a genome-wide analysis of observational data and large randomised controlled trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kamil Banasik, Patrick Baum, Jimmy D. Bell, Mats Bergström, Joline W. J. Beulens, Susaana Bianzano, Roberto Bizzotto, Amelie Bonneford, Caroline Brorsson, A.A. Brown, S.B. Brunak, Louise Cabrelli, Robert Caïazzo, Mickaël Canouil, M.M. Dale, David Davtian, Adem Y. Dawed, F.M. De Masi, Nathalie de Préville, Koen F. Dekkers, E. T. Dermitzakis, Harshal Deshmukh, Christiane Dings, Louise Donnelly, Avirup Dutta, Beate Ehrhardt, Petra J. M. Elders, Cecilia Engel Thomas, Line Engelbrechtsen, R.G. Eriksen, R.E. Eriksen, Yong Fan, J. Fernandez, José Illnait Ferrer, Hugo Fitipaldi, Ian Forgie, Axel Forman, Paul W. Franks, Franco Frau, A. Fritsche, P. Froguel, Gary Frost, Johann Gassenhuber, Guillermo Giordano, Toni Giorgino, Stephen Gough, Ulrike Graefe‐Mody, H. Grallert, Rolf Grempler, Lenka Groeneveld, Leif Groop, V Gudmundsdottir, R.G. Gupta, Mark Haid, T. Hansen, Tue H. Hansen, Andrew T. Hattersley, Ragna S. Häussler, A.J. Heggie, Anita M. Hennige, Adrian V. S. Hill, Reinhard W. Holl, Mun‐Gwan Hong, Michelle Hudson, Bernd Jablonka, Christopher Jennison, Jian Jiao, Jon Johansen, Adam G. Jones, A. Jonsson and 78 more - The Lancet Diabetes & Endocrinology 2022 cited by 105

  5. Bayesian refinement of association signals for 14 loci in 3 common diseases

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , John A. Todd, Dominic Kwiatkowski, Nilesh J. Samani, Stephen Gough, Mark I. McCarthy, Panagiotis Deloukas, Peter Donnelly - Nature Genetics 2012 cited by 553

  6. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hin-Tak Leung, Chris Wallace, Joanna M. M. Howson, Cristian Guja, C Ionescu-Tîrgovişte, Matthew J. Simmonds, J. M. Heward, Stephen Gough, David B. Dunger, Linda S. Wicker, David Clayton - Nature Genetics 2007 cited by 1,457

  7. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael L. Metzker, Jane Rogers, Simon G. Gregory, Amit Allahabadia, Ratnasingam Nithiyananthan, Eva Tuomilehto‐Wolf, Jaakko Tuomilehto, Polly J. Bingley, Kathleen M. Gillespie, Dag E. Undlien, Kjersti S. Rønningen, Cristian Guja, C Ionescu-Tîrgovişte, David A. Savage, Alexander P. Maxwell, D. J. Carson, C. C. Patterson, Jayne A. Franklyn, David Clayton, Laurence B. Peterson, Linda S. Wicker, John A. Todd, Stephen Gough - Nature 2003 cited by 2,183

  8. Current and future therapies for type 1 diabetes

    Authors: , , , - Diabetologia 2021 cited by 141

  9. The HLA Region and Autoimmune Disease: Associations and Mechanisms of Action

    Authors: , - Current Genomics 2007 cited by 490

  10. Efficacy and safety of a fixed-ratio combination of insulin degludec and liraglutide (IDegLira) compared with its components given alone: results of a phase 3, open-label, randomised, 26-week, treat-to-target trial in insulin-naive patients with type 2 diabetes

    Authors: , , , , , , , - The Lancet Diabetes & Endocrinology 2014 cited by 362

  11. Safety and efficacy of liraglutide in patients with type 2 diabetes and elevated liver enzymes: individual patient data meta‐analysis of the LEAD program

    Authors: , , , , , , , - Alimentary Pharmacology & Therapeutics 2012 cited by 248

  12. Sex and BMI Alter the Benefits and Risks of Sulfonylureas and Thiazolidinediones in Type 2 Diabetes: A Framework for Evaluating Stratification Using Routine Clinical and Individual Trial Data

    Authors: , , , , , , , , , , , , , , , , , , , , - Diabetes Care 2018 cited by 135

  13. Prevalence and Relative Risk of Other Autoimmune Diseases in Subjects with Autoimmune Thyroid Disease

    Authors: , , , , , , , , , , , , , , - The American Journal of Medicine 2010 cited by 468

  14. Glucagon‐like peptide‐1 receptor agonists to expand the healthy lifespan: Current and future potentials

    Authors: , , , - Aging Cell 2023 cited by 26

  15. Influences of Age, Gender, Smoking, and Family History on Autoimmune Thyroid Disease Phenotype

    Authors: , , , , , , , , , , - The Journal of Clinical Endocrinology & Metabolism 2006 cited by 254

  16. Profiles of Glucose Metabolism in Different Prediabetes Phenotypes, Classified by Fasting Glycemia, 2-Hour OGTT, Glycated Hemoglobin, and 1-Hour OGTT: An IMI DIRECT Study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Martin Ridderstråle, Tue H. Hansen, Kristine H. Allin, Torben Hansen, Henrik Vestergaard, Andrea Mari, Leen M. ‘t Hart, Moustafa Abdalla, Jonathan Adam, Jerzy Adamski, Kofi P. Adragni, Rosa Lundbye Allesøe, Kristine H. Allin, Manimozhiyan Arumugam, Naeimeh Atabaki Pasdar, Tania Baltauss, Karina Banasik, Patrick Baum, Jimmy D. Bell, Margit Bergstrom, Joline W. J. Beulens, Susaana Bianzano, Roberto Bizzotto, Amelie Bonneford, Caroline Brorsson, Andrew Brown, Søren Brunak, Louise Cabrelli, Robert Caïazzo, Mickaël Canouil, Henna Cederberg, Matilda Dale, David Davtian, Adem Y. Dawed, Federico De Masi, Nathalie de Préville, Koen F. Dekkers, Emmanouil T. Dermitzakis, Harshal Deshmukh, Christiane Dings, Louise A. Donnelly, Avirup Dutta, Beate Ehrhardt, Petra J. M. Elders, Line Engelbrechtsen, Rebeca Eriksen, Yong Fan, Juan Fernandez, Jorge Ferrer, Hugo Fitipaldi, Ian M. Forgie, Annemette Forman, Paul W. Franks, Francesca Frau, Andreas Fritsche, Philippe Froguel, Gary Frost, Johann Gassenhuber, Giuseppe N. Giordano, Toni Giorgino, Stephen Gough, Ulrike Graefe‐Mody, Harald Grallert, Rolf Grempler, Lenka Groeneveld, Leif Groop, Valborg Guðmundsdóttir, Ramneek Gupta, Mark Haid, Torben Hansen and 95 more - Diabetes 2021 cited by 42

  17. Identification of Novel Genetic Loci Associated with Thyroid Peroxidase Antibodies and Clinical Thyroid Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , W. Edward Visser, Andrew T. Hattersley, Jürgen Kratzsch, Alexander Hamilton, Wěi Li, Georg Homuth, Monia Lobina, Stefano Mariotti, Nicole Soranzo, Massimiliano Cocca, Matthias Nauck, Christin Spielhagen, Alec Ross, Alice M. Arnold, Martijn van de Bunt, Sandya Liyanarachchi, Margit Heier, Hans J. Grabe, Corrado Masciullo, Tessel E. Galesloot, Ee Mun Lim, Eva Reischl, Peter J. Leedman, Sandra Lai, Alessandro Delitala, Alexandra Bremner, David I. W. Philips, John Beilby, Antonella Mulas, Matteo Vocale, Gonçalo R. Abecasis, Tom Forsén, Alan James, Elisabeth Widén, Jennie Hui, Holger Prokisch, Ernst E. Rietzschel, Aarno Palotie, Peter Feddema, Stephen J. Fletcher, Katharina Schramm, Jerome I. Rotter, Alexander Kluttig, Dörte Radke, Michela Traglia, Gabriela Surdulescu, Huiling He, Jayne A. Franklyn, Daniel Tiller, Bijay Vaidya, Tim De Meyer, Torben Jørgensen, Johan G. Eriksson, Peter O’Leary, Eric Wichmann, Ad R. Hermus, Bruce M. Psaty, Till Ittermann, Albert Hofman, Emanuele Bosi, David Schlessinger, Henri Wallaschofski, Nicola Pirastu, Yurii S. Aulchenko, Albert de la Chapelle, Romana T. Netea‐Maier, Stephen Gough, Henriette E. Meyer zu Schwabedissen, Timothy M. Frayling, Jean‐Marc Kaufman and 18 more - PLoS Genetics 2014 cited by 218

  18. Genetic analysis of blood molecular phenotypes reveals common properties in the regulatory networks affecting complex traits

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Miranda Mourby, Petra B. Musholt, Birgitte Nilsson, François Pattou, Deborah Penet, Violeta Raverdy, Martin Ridderstråle, Luciana Romano, Femke Rutters, Sapna Sharma, Harriet Teare, Leen M. ‘t Hart, Konstantinos D. Tsirigos, Jagadish Vangipurapu, Henrik Vestergaard, Søren Brunak, Paul W. Franks, Gary Frost, Harald Grallert, Bernd Jablonka, Mark I. McCarthy, Imre Pávó, Oluf Pedersen, Hartmut Ruetten, Mark Walker, Kofi P. Adragni, Rosa Lundbye Allesøe, Anna A. Artati, Manimozhiyan Arumugam, Naeimeh Atabaki‐Pasdar, Tania Baltauss, Karina Banasik, Anna Barnett, Patrick Baum, Jimmy D. Bell, Joline W. J. Beulens, Susanna Bianzano, Roberto Bizzotto, Amélie Bonnefond, Louise Cabrelli, Matilda Dale, Adem Y. Dawed, Nathalie de Préville, Koen F. Dekkers, Harshal Deshmukh, Christiane Dings, Louise A. Donnelly, Avirup Dutta, Beate Ehrhardt, Line Engelbrechtsen, Rebeca Eriksen, Yong Fan, Jorge Ferrer, Hugo Fitipaldi, Annemette Forman, Andreas Fritsche, Philippe Froguel, Johann Gassenhuber, Stephen Gough, Ulrike Graefe‐Mody, Rolf Grempler, Lenka Groeneveld, Leif Groop, Valborg Guðmundsdóttir, Ramneek Gupta, Anita M. Hennige, Anita Hill, Reinhard W. Holl, Michelle Hudson, Ulrik Plesner Jacobsen and 54 more - Nature Communications 2023 cited by 51

  19. Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus

    Authors: , , , , , , , , , , , , , , , , - Nature Genetics 1995 cited by 754

  20. FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity

    Authors: , , , , , , , , , , , , , , , , , , , - Nature Genetics 2007 cited by 465

  21. Management of peripheral arterial disease in primary care

    Authors: , , - BMJ 2003 cited by 179

  22. Age and Gender Predict the Outcome of Treatment for Graves’ Hyperthyroidism*

    Authors: , , , , , - The Journal of Clinical Endocrinology & Metabolism 2000 cited by 251

  23. One‐year efficacy and safety of a fixed combination of insulin degludec and liraglutide in patients with type 2 diabetes: results of a 26‐week extension to a 26‐week main trial

    Authors: , , , , , , , - Diabetes Obesity and Metabolism 2015 cited by 123

  24. Analysis of HLA class II genes in Hashimoto's thyroiditis reveals differences compared to Graves’ disease

    Authors: , , , , , , - Genes and Immunity 2008 cited by 100